[Lipid decreasing effect of trans-2,10-dichloro-6-ethoxycarbonyl-12-methyldibenzo[d,g] [1,3]dioxocin (EGYT-1932, Crismel)].
D000818:Animals; D002994:Clofibrate / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D006949:Hyperlipidemias / Q000097:blood; D000960:Hypolipidemic Agents; D051381:Rats
D006571:Heterocyclic Compounds; D000960:Hypolipidemic Agents; C020876:Crismel; D002994:Clofibrate
Transz-2,10-diklór-6-etoxikarbonil-12-metil-dibenzo [d,g] [1,3]-dioxocin (EGYT-1932, Crismel) lipidcsökkentö hatásának vizsgálata.